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Transmembrane helixOligomerization of hepatitis C viral envelope proteins E1 and E2 is essential to virus fusion and assembly. Al-
though interactions within the transmembrane (TM) domains of these glycoproteins have proven contributions
to the E1/E2 heterodimerization process and consequent infectivity, there is little structural information on this
entry mechanism. Here, as a ﬁrst step towards our long-term goal of understanding the interaction between E1
and E2 TM-domains, we have expressed, puriﬁed and characterized E1-TM using structural biomolecular NMR
methods. An MBP-fusion expression system yielded sufﬁcient quantities of pure E1-TM, which was solubilized
in twomembrane-mimicking environments, SDS- and LPPG-micelles, affording samples amenable to NMR stud-
ies. Triple resonance assignment experiments and relaxation measurements provided information on the sec-
ondary structure and global fold of E1-TM in these environments. In SDS micelles E1-TM adopts a helical
conformation, with helical stretches at residues 354–363 and 371–379 separated by a more ﬂexible segment
of residues 364–370. In LPPG micelles a helical conformation was observed for residues 354–377 with greater
ﬂexibility in the 366–367 dyad, suggesting LPPG provides a more native environment for the peptide. Replace-
ment of key positively charged residue K370 with an alanine did not affect the secondary structure of E1-TM
but did change the relative positioning within the micelle of the two helices. These results lay the foundation
for structure determination of E1-TM and amolecular understanding of howE1-TMﬂexibility enhances its inter-
action with E2-TM during heterodimerization and membrane fusion.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
1.1. The hepatitis C virus
Hepatitis C virus (HCV) is the secondmost common chronic viral in-
fection, estimated to afﬂict 3% of the world population, causing chronic
hepatitis, cirrhosis, hepatic carcinomas as well as extra-hepatic diseases
[1]. TheHCVgenomeencodes a ~3000 amino-acid long polypeptide pre-
cursor which is later co- and post-translationally processed into at least
10mature proteins [2]. Of these, the structured proteins, the core protein
and envelope glycoproteins E1 and E2, form the viral particle, while the
non-structured proteins are involved in the replication cycle and its reg-
ulation through protease, helicase and polymerase activities [3]. Despite
progress in our understanding of HCV biology, improvements upon theell–Meiboom–Gil (pulse-train);
phocholine; DSS, 4,4-dimethyl-
HCV, hepatitis C virus; HSQC,
l β-D-1-thiogalactopyranoside;
-rac-glycerol); MBP, maltose-
R, nuclear magnetic resonance;
protease); TM, transmembrane
ights reserved.only partially effective interferon/ribavirin treatment regimen, such as
protease inhibitors, nucleoside inhibitors, and monoclonal antibodies,
have been slow, and plagued by mediocre response levels and undesir-
able side-effects [4].
1.2. The E1/E2 heterodimer is critical to viral infectivity
E1 and E2 are both type I membrane proteins (MPs) each comprised
of a large heavily glycosylated N-terminal ectodomain, a single mem-
brane spanning domain and a short C-terminal cytoplasmic tail. The
two glycoproteins assemble into a heterodimerwhich is themajor com-
ponent of the viral envelope and obligatory for viral infectivity [5]. Sev-
eral studies have investigated the interaction mode between the two
ectodomains and their contribution to the fusion process [6–8]. The E2
ectodomain is also known to recognize the host tetraspannin CD81 re-
ceptor, an important step en route to membrane fusion and viral entry
[9,10], and anti-E2 antibodies are currently under investigation as HCV
therapies [11]. However, study of themembrane-spanning (transmem-
brane, TM) domains has proven more challenging. It is known that be-
sides directing and anchoring E1 and E2 to the endoplasmic reticulum
and acting as signal sequences, these segments, E1-TM and E2-TM, are
major contributors to the assembly of the E1-E2 heterodimer [12].
Mutational studies of the TM domains, each adopting α-helical confor-
mations and ~30 amino acids long, identiﬁed structural elements
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lular side of E1-TM, and charged residues K370 on E1-TM, and D728 and
R730 on E2-TM [13,14] (See Fig. 1).Mutations at these positions resulted
in typical 3 to 4-fold reductions in heterodimer formation. In light of re-
cent advances in targeting TMdomains for drug discovery [15], amolec-
ular understanding of dimerization in themembrane-embedded region
of the E1/E2 heterodimer is of great interest.
1.3. Bitopic membrane proteins and their study by NMR
The TM-domains of the E1/E2 heterodimer form a bitopic system, an
architecture which represents more than half of MPs in analyzed ge-
nomes [16]. This is an arrangement of two single-TM helical membrane
spanning domains which assume a parallel orientation and associate
within the membrane via non-covalent interactions. Several disease-
causing mutations have been found in bitopic systems, highlighting
their independent importance in both health and disease [17,18]. The
interactions between membrane helical domains have drawn great in-
terest because of their importance in folding, structure and stability in
polytopic MPs, and because the association of two monotopic MPs is a
paradigm of cellular signaling. As for all MPs, membrane helical seg-
ments challenge structural methods such as X-ray crystallography and
nuclearmagnetic resonance (NMR), since such peptidesmust be solubi-
lized in a membrane-mimicking environment, greatly complicating
sample preparation and data acquisition. Nevertheless, signiﬁcant prog-
ress in the ability of NMR to address membrane-embedded peptides
and bitopic MPs has been recently reported [19,20]. MPs can be studied
using NMR by solubilization in micelles or disc-like bicelles formed by
detergents or phospholipids [21–24] or assembled nano-discs [25],
which serve as surrogate membranes and stabilize the protein in aque-
ous environment. Solution state NMR allows investigation in solution,
an environment which closely mimics that of native MPs, and is sensi-
tive to dynamic processes on a wide range of timescales unobservable
using other methods [26,27]. In addition, several NMR-based methods
are available for studying protein–protein interactions [27–30], includ-
ing potentially weak (above μM afﬁnity) interactions between TM do-
mains [31,32], and NMR excels at studying the overall fold of proteins
comprised of multiple locally rigid domains by analyzing their interac-
tions and relative orientations [33].
Here we harness the abilities of solution NMR to provide a structural
characterization of the E1-TM domain from theHCV envelope glycopro-
tein. Focusing on amembrane-spanning peptide solubilized in detergent
and phospholipid micelles, we show it adopts a helical conformation
under these conditions, with the length of the helical segments depend-
ing on the micelle composition. 15N relaxation rates and measurements
of solvent accessibility are utilized to characterize the architecture and
biophysical behavior of the peptide embedded in themicelle. These ﬁnd-
ings lay the necessary foundations for a comprehensive study ofFig. 1. The E1/E2 glycoprotein heterodimeric system inHCV. Left, schematic representation of th
viralmembrane. Right, membrane-spanning sequences of E1 (E2),with residues known to be in
are the MBP carrier protein, TEV cleavage site, and the E1-TM segment employed in this studyinteractions between transmembrane segments of E1/E2 en route to
their association.
2. Materials and methods
2.1. Media and solvents
Custom synthesized DNA oligomers (primers) with codon usage op-
timized for E. coli, sodium dodecylsulphate (SDS), and Isogro-DCN
supplement for triply labeledmedia were obtained from Sigma–Aldrich
(St. Louis, MO, USA). Isotopically labeled chemicals for constructing la-
beling media, including 2H2O, 13C-labeled glucose and 15NH4Cl, were
purchased from Cambridge Isotope Laboratories (Andover, MA, USA).
Dodecylphosphocholine (DPC) was purchased from Affymetrix (Mau-
mee, OH, USA) and dihexanoylphosphatidylcholine (DHPC) and 1-
palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-glycerol) (LPPG)
were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). M9
minimal media was made as previously described [34], with substitu-
tion of 15NH4Cl, 13C6-glucose and 2H2O for producing isotope-labeled
E1-TM. HPLC grade solvents HCOOH and iso-C3H8OH were purchased
from Biolabs (Jerusalem, Israel).
2.2. Cloning of the E1-TM sequence
The coding sequence for E1-TM (GeneArt, Regensburg, Germany)
was inserted into a pETMBP-TEVH vector, a modiﬁed pET28a(+) con-
struct containing the maltose binding protein (MBP) coding sequence
[35], between the KpnI and XhoI restriction sites. This was accom-
plished by overlap extension using the polymerase chain reaction
(PCR)-based restriction site-free cloning (RF-cloning) essentially as pre-
viously described [36]. In the ﬁrst PCR, an E1-TM-carrying pET41a plas-
mid was incubated with primers E1-TM 5′ and E1-TM 3′ to amplify a
double stranded DNA fragment that included the coding sequence for
33 E1 residues (351–383), ﬂanked on either side by six additional
amino acids to increase peptide solubility, and complementary se-
quences to pET-MBP-TEVH. This resulted in an E1-TM-encoding
megaprimer which was carried over to the second stage. The second
PCR utilized vector pET-MBP-TEVH as DNA template and the puriﬁed
mega primer. The plasmid was ampliﬁed in E. coli DH5α cells. The
DNA sequence of the obtained plasmid, referred to as pET-MBP-
TEVH_E1, was conﬁrmed by DNA sequencing. E. coli BL-21 competent
cells were transformed with plasmid pET-MBP-TEVH_E1 for expression
of a fusion protein comprised of 380 residues ofMBP, a 17 residue linker
containing a His6-tag and a tobacco etch virus (TEV) protease cleavage
site, the 45 residue DPEREK-(E1-TM)-EREKDP sequence, followed by a
His8-tag (Fig. 1). The K370A mutant was created using a QuikChange
kit (Stratagene, Santa Clara, CA, USA).eHCV E1 (yellow) and E2 (red) glycoproteins, emphasizing the segments embedded in the
volved in heterodimerization highlighted in yellow (red), and the E1-TMconstruct. Shown
, including residues added for solubility enhancement.
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E1-TM was expressed in M9 minimal medium using previously de-
scribed protocols [34]. 15N- and 13C-isotope labeling was achieved
using 1 g/L 99% 15NH4Cl and 2.5 g/L 99% 13C6-glucose, respectively. Brief-
ly, E. coli BL21 cells were grown in M9 minimal media at 37 °C to an
OD600 of 0.8, at which point isopropyl-thio-galactose (IPTG) was added
to a ﬁnal concentration of 1.0 mM and induction proceeded at 27 °C
overnight. For preparation of deuterated samples, 200 mL of H2O-based
M9 culture was grown at 37 °C until the OD600 ~ 0.5 level was reached.
Then, cells were gently spun down (1400 g, 20 minutes at ambient tem-
perature) and resuspended in 1 L D2O-based M9 culture supplemented
with 1 g/L Isogro-DCN dry powder (Sigma–Aldrich, St, Louis, MO, USA).
Then cells were grown again to the OD600 ~ 0.8 level, induced, and
grown overnight at 27 °C. Cells were harvested by centrifugation and
lysed by homogenization (C5 homogenizer, Avestin) in lysis buffer
(20 mM NaPi, pH 7.4, 500 mM NaCl, 20 mM imidazole, 1 mM dithio-
threitol (DTT)). The clariﬁed lysate was applied on a HiTrap Chelating
HP column (GE Healthcare, Uppsala, Sweden.) charged with Ni2+. The
column was washed with several column volumes of lysis buffer, and
bound protein was then eluted by raising the imidazole concentration
to 500 mM. The elutewas dialyzed for 12–14 h at 25 °C against TEV pro-
tease cleavage buffer (20 mM NaPi, pH 7.5, 150 NaCl and 1 mM DTT),
and later incubated with TEV protease (1:10 w\w) for 5 h at 30 °C,
resulting in quantitative cleavage of the E1-TMpeptide from itsMBP car-
rier. The E1-TM peptide was puriﬁed by RP-HPLC (Young-Lin, Kyounggi-
do, Republic of Korea) using a preparative C4 column (Phenomenex, Tor-
rance, CA, USA) at 60 °C and a H2O:isopropanol linear gradient (30:70 to
50:50) containing 10% (v/v) formic acid. Fractions containing E1-TM
were pooled and lyophilized, after which they could be solubilized in de-
tergent for NMR experiments. Protein concentration was determined by
measuring the absorbance at 280 nm, based on a speciﬁc absorbance of
2.2 OD280 for a 1 mg/mL solution.
2.4. Circular dichroism measurements
CD experiments were acquired on a Chirascan polarimeter (Applied
Photophysics, Surrey, United Kingdom) for a 15 μM samples of E1-TM
peptide solubilized in SDS, LPPG, or DPC, in 20 mM NaPi buffer,
pH 6.5. Typical detergent:peptide molar ratios were 600–1500:1 to en-
sure single occupancy of micelles by the peptide. Samples were placed
in a 1 mm cuvette and the 180–260 nm range was scanned in 0.5 nm
steps with a bandwidth of 2 nm. Each experiment was repeated three
times and subtracted from ameasurement of an identical buffer sample.
Resultswere analyzed using the CDSSTRmodule of theDichroWebplat-
form for the 190–240 nm range[37].
2.5. NMR spectroscopy
All 2D- and 3D-NMR measurements were conducted on a DRX700
Bruker (Bruker BioSpin, Karlsruhe, Germany) spectrometer using a
cryogenic triple-resonance TCI probehead equipped with z-axis pulsed
ﬁeld gradients. NMR samples containing 0.3–0.6 mM E1-TM (wildtype
or K370A mutant) were prepared in 20 mM phosphate buffer, with pH
values of 6.0–6.5, 20 mM NaCl, 7% 2H2O, and an appropriate detergent,
and placed in a 5 mm Shigemi (Shigemi, Allison, PA, USA) or Wilmad
(Wilmad Labglass, Vineland, NJ, USA) NMR tube. Measurements were
conducted at 318 K. Transverse relaxation-optimized (TROSY) 1H,15N-
HSQC experiments (tr-HSQC) for screening of measurement conditions
were acquired using a standard sequence run for 30–60 min. For back-
bone assignment, TROSY-based triple resonance HNCO, HNCA, HN(CO)
CACB, and HNCACB experiments using sensitivity-enhanced echo-
antiecho detection [38]were acquired for partially deuterated, uniform-
ly 13C,15N-labeled E1-TM. All triple-resonance experiments were typi-
cally acquired with 32–36 complex points and an acquisition time of
20.2–22.8 ms in the 15N dimension, and 512 complex points and anacquisition time of 52.2 ms in the observed dimension. In the 13C di-
mension, experiments with 13CO (13Cα) evolution were acquired with
32–40 complex points and 21.2–26.5 (7–7.5) ms acquisition time, and
experiments with 13Cα/β evolution were acquired with 56–64 complex
points and 5.3–6.1 ms acquisition time. All spectra were processed
using the TopSpin 2.1 package (Bruker BioSpin, Karlsruhe, Germany).
Chemical shifts were referenced indirectly against 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS).
Relaxation measurements were conducted in scan-by-scan inter-
leaved fashion with a tr-HSQC spectrum for readout at static magnetic
ﬁeld of 16.4 T and 318 K. To ensure sufﬁcient resolution in the 2D spec-
trum, acquisition times were set to 104.5 ms and 58–70 ms in the 1H-
and 15N-dimensions, respectively. Longitudinal relaxation rates (R1)
were estimated from a series of decay spectra with delays of 2
(reference spectrum), 152, 302, 502, 702, 902, and 1202 ms. Similarly,
transverse relaxation rates (R2) were estimated from a series of decay
spectra using a Carr–Purcell–Meiboom–Gil (CPMG) relaxation block
with delays of 16.96 (reference spectrum), 33.92, 50.88, 67.84, 84.80,
101.76, and 135.68 ms. The heteronuclear 15N-{1H}-NOEs (hetNOEs)
were determined by recording pairs of interleaved spectra with and
without proton saturation during the recycle delay [39,40]. A total of
16 transients were collected per t1 experiment and delays between
scans were 3.0 s. Total experiment time for each relaxation measure-
ment was 42–48 h. In both cases intensities were ﬁt to an exponential
decay function using the Bruker TopSpin 2.1 Dynamics suite, and
hetNOEs were derived from the intensity ratio in reference and attenu-
ated spectra.
3. Results
3.1. Design and biosynthesis of the E1-TM peptide
Due to their hydrophobicity, TM domains are notoriously difﬁcult to
prepare using solid-phase synthesis methods. We therefore set out to
express E1-TMusing a fusion protein system. The E1 sequencewas cho-
sen from a consensus sequence of viral strains. Several studies have fo-
cused on the location of the membrane-spanning domain of the E1
glycoprotein, with a general agreement that residues 353 to 383 should
include this domain [41–43]. A recent study utilized multiple bioinfor-
matics tools to further pinpoint the location of the hydrophobic stretch
of residues traversing themembrane, suggesting this region to span res-
idues 354–379 [44], in agreement with earlier predictions [14]. There-
fore, we chose a 33-residue segment of E1 (A351HWGVLAGLAYYSM
VGNWAKVLIVLLLFAGVDA383), to which we added a hexa-residue pep-
tide on either side (DPEREK and EREKDP at the N- and C-terminii, re-
spectively) in order to increase its solubility (Fig. 1). The alternatingly
charged residueswere chosen to increase solubility inwaterwithout af-
fecting the overall electrostatic properties of the peptide. The resulting
polypeptide was fused to MBP [45] via a TEV protease cleavage site.
This 50 kDa protein (including the His8-tag) could be expressed as a
soluble polypeptide, presumably due to the ability of MBP to stabilize
the hydrophobic E1-TM and preclude aggregation. SDS-PAGE analysis
showed TEV cleavage to be complete, but E1-TM remained bound to
the fusion protein as evidenced by size exclusion chromatography.
Due to their different hydrophobic character, the desired TM peptide
could be separated from the fusion protein by RP-HPLC on a C4 column
at strongly acidic conditions (10% HCOOH, 60 °C) and a H2O:
isopropanol gradient (Supporting Information, Fig. S1). Lyophilized
E1-TM could then be solubilized in a detergent of choice in preparation
for NMR and CD experiments.
3.2. Characterization and resonance assignment of E1-TM
The choice of detergent for solubilization of membrane peptides is
known to have far-reaching consequences on the ability to study their
structure using NMR as well as the biological interpretation of these
787H. Zazrin et al. / Biochimica et Biophysica Acta 1838 (2014) 784–792results [22,24,46,47]. We therefore prepared samples of E1-TM solubilized
by four different detergents and phospholipids, sodium dodecylsulphate
(SDS), dodecylphosphocholine (DPC), dihexanoylphosphatidylcholine
(DHPC) and 1-palmitoyl-2-hydroxy-sn-glycero-3-phospho-(1′-rac-
glycerol) (LPPG). Initial characterization of these samples was
performed using circular dichroism (CD). The SDS- and LPPG-
solubilized E1-TM produced CD curves with the characteristic minima
at 208 and 222 nm, indicating the prevalence of α-helical secondary
structure in the detergent-solubilized peptides. Notably, the LPPG sam-
ple appeared to contain more helical character than the SDS sample. In
contrast, in DPC andDHPC E1-TMexhibited considerably less secondary
structure, suggesting it was not properly stabilized in native form at
these conditions (Fig. 2A). Using the DichroWeb CDSSTR module [37]
we determined that the proportion of helical (β-sheet) character in
E1-TM was 38 (13), 51 (9), 28 (26) and 14 (33) % in SDS, LPPG, DPCFig. 2. Characterization of E1-TM in various membrane-mimicking environments. Bio-
physical behavior of E1-TM was characterized in various detergents and phospholipids.
A) Circular dichroism curves of E1-TM solubilized in 40 mM SDS (red), 40 mM LPPG
(blue), 40 mM DPC (black) and 30 mM DHPC (grey). (B) tr-1H–15N-HSQC spectra of
0.6 mM E1-TM solubilized in various detergents were used to characterize the samples
and optimize measurement conditions. All were acquired for detergent-solubilized E1-
TM in 20 mM NaCl, 20 mM phosphate buffer at pH 6.7, and at a ﬁeld strength of 16.4 T
and a temperature of 318 K. Shown from the upper left corner in clockwise fashion are
spectra in DPC, DHPC, SDS and LPPG.andDHPC, respectively (Table 1). CD curveswere insensitive to changes
in temperature in the 298–318 K range.
We continued this characterization by comparing tr-1H,15N-HSQC
spectra of these four samples. This demonstrated that detergents with
negatively charged headgroups, SDS and LPPG, are suitable for studying
E1-TM. Although both spectra exhibited low spectral resolution charac-
teristic of helical membrane segments, 41 (in SDS) and 43 (in LPPG)
crosspeaks were observed, close to the number expected for E1-TM. In
contrast, both phosphocholine detergents afforded low-quality spectra
with limited signal-to-noise and several absent cross-peaks (Fig. 2B).
Speciﬁcally, none of the expected four cross-peaks arising from Gly res-
idues could be observed in these detergents, whereas SDS- and LPPG-
solubilized samples exhibited all such peaks. As E1-TM is predicted to
be a helical membrane-spanning peptide, this is consistent with the
higher helical contents found by CD in SDS and LPPG.
SDSand LPPG are located on opposite ends of the range of detergents
suitable for structural NMR of membrane peptides. SDS assembles into
smaller micelles [46], resulting in improved linewidths, and while it
will stabilize the membrane-embedded residues, its strongly charged
headgroup and relatively short aliphatic tail often force peptides to
adopt less-than-native conformations. In contrast, the more biological
nature of the LPPG headgroup and its longer fatty acid chain make
LPPGmicelles a useful and NMR-amenablemembrane-mimicking envi-
ronment [22], even though relaxation losses for the larger micellar as-
sembly may be of some consequence. Thus, we proceeded to prepare
triply [2H,13C,15N]-labeled E1-TM samples solubilized in SDS and LPPG
micelles in order to compare the conformations adopted by the peptide
in the two environments.
3.3. Secondary structure of E1-TM in detergent and phospholipid micelles
Backbone resonances were assigned for the E1-TM peptide solubi-
lized in SDS and LPPG micelles using a combination of TROSY versions
of the HNCO, HN(CA)CO, HNCA, HNCOCACB, and HNCACB experiments
[38]. While spectra obtained in both micelles exhibit relatively poor
spectral dispersion which is characteristic of helical membrane seg-
ments, the above experiments were sufﬁcient to assign the majority of
backbone residues. Fig. 3 displays sample strip plots demonstrating
the connectivities established between adjacent residues as derived
from the triple-resonance tr-HN(CA)CO and tr-HNCA experiments,
and the fully-assigned HSQC spectrum for the LPPG-solubilized sample.
The resonance assignment of E1-TM solubilized in SDS and LPPG mi-
celles has been deposited in the Biological Magnetic Resonance Data
Bank (BMRB), under accession code 19517. Differences between theﬁn-
gerprint spectra and backbone chemical shifts in SDS (Supporting Infor-
mation, Fig. S2) and LPPG (Fig. 3) indicated that the peptide adopted a
characteristic conformation in each of the two micelles. Analysis of
13C`, 13Cα, and 13Cβ secondary chemical shifts [48] in SDS (assignment
level of 85% for 1H–15N pairs and 84% for backbone 13C nuclei) showed
that within the membrane domain E1-TM adopted a helical conforma-
tion, with helices spanning residues 354–363 (H1) and 371–379 (H2)
connected by a 7-residue segment (364–370) in random coil conforma-
tion (Fig. 4). Residues 380–382 at the micelle–solution interface could
not be observed, presumably lost to exchange-broadening which may
result from hydrophobic mismatch between the peptide and the SDSTable 1
Secondary structure in E1-TM.
%sheet (CD)a %helix (CD)a %helix (NMR)b
SDS 13 38 36
LPPG 9 51 45
DPC 26 28 NDc
DHPC 33 14 NDc
a As determined by the CDSSTR module of the DichroWeb platform (ref. [37]).
b As determined by δ2D analysis of chemical shifts (ref. [48]).
c Not determined.
Fig. 3. Backbone assignment of E1-TM. Left, Strip plots derived from the tr-HNCA and tr-HN(CA)CO spectra of LPPG-solubilized E1-TM demonstrating the ‘backbone-walk’ which made
possible the assignment of chemical shifts for residues 354–358 of the GxxxG motif. Right, The fully assigned tr-HSQC spectrum of E1-TM in LPPG micelles.
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mation in LPPG micelles (assignment level of 97% for 1H–15N pairs and
95% for backbone 13C nuclei). Here a helical conformationwas observed
throughout E1-TM, spanning residues 354–377. Residues G366 and
N367 exhibited lower helical propensity, suggesting this dyad embodies
a more ﬂexible region within the helix. Signiﬁcantly, residues 380–383
were now clearly visible, testifying to the fact that E1-TM is better stabi-
lized by the long-chain andmore biologically relevant LPPG. Helical con-
tent of E1-TMdetermined by secondary chemical shift analysis, 19 of 53
residues, or 36%, for SDS, and 24 of 53 residues, or 45%, for LPPG, were in
reasonable agreement with the previously mentioned CD results (38
and 51%, respectively, Table 1).3.4. Characterization of the E1-TM/LPPG macroassembly
We further probed the architecture of the E1-TM-containing LPPG
micelle by measuring 15N relaxation rates, a reliable reporter on back-
bone dynamics on the ps-ns timescale [39,49], and solvent accessibility
of 1H–15N amide moieties, along the E1-TM backbone. R1 and R2 rates
and hetNOEs were measured for LPPG-solubilized E1-TM at 318 K and
16.4 T. Elevated R1 values (1.2–1.4 s−1) and reduced R2 and hetNOEFig. 4. Secondary chemical shifts of E1-TM deﬁne its fold. Secondary chemical shifts mea-
sured along the E1-TM backbone. Shown are values for 13C’ (top), 13Cα (middle) and 13Cβ
(bottom) nuclei in SDS (empty bars) and LPPG (ﬁlled bars), respectively. The H1, H2 seg-
ments are designated by cylinders above the ﬁgure.values (5–7 s−1 and 0.4–0.5, respectively) were seen for residues
350–353 and 380–383, indicating that these segments aremore ﬂexible
and therefore reside outside of the LPPGmicelle. In contrast, the lowerR1
values (0.85–1.0 s−1) and increased R2 and hetNOE values (15–20 s−1
and 0.7–0.8, respectively) observed for residues 354–379 are character-
istic of a more rigid domain, and unambiguously deﬁne the membrane-
spanning region of the peptide (Fig. 5A–C). Residues N367, W368 and
A369 differ in their relaxation parameters (higher R1, lower R2) in com-
parison to the entire membrane-spanning domain, conﬁrming them as
comprising a more ﬂexible linker between structural elements. The
ratio R2/R1 in the helical regions lies in the 18 to 20 range, predicting a
global tumbling time of ~12 ns for the E1-TM-containing micelle at
318 K,which, based on the Stokes–Einstein equation for rotational diffu-
sion of a spherical body, corresponds to amolecularweight of ca. 70 kDa.
This is consistent with the known size of LPPG micelles, determined to
be ~64 kDa [50], and the mass of E1-TM, slightly over 6 kDa.
Close examination of the R2/R1 ratios in the E1-TM hydrophobic
domain distinguishes between relaxational behavior of H1 and H2
(Fig. 5D). The GVALG motif in H1 (residues 354–358) exhibits a lower
R2/R1 ratio of 14 (range 12–15), others H1 residues (359–366) exhibit
a higher ratio, 18 (range 17.3–20.1), whereas H2 (residues 371–378)Fig. 5. Relaxation measurements report on ps-ns dynamics of the E1-TM-LPPG assembly.
Backbone 15N relaxation rates measured for 2H,13C,15N-labeled E1-TM at a static ﬁeld of
16.4 T and 318 K. Shown are relaxation rates (A) longitudinal relaxation R1, (B) transverse
relaxation R2, and (C) the heteronuclear 15N-{1H}-NOE. Typical errors in relaxation rate
measurements (shown in error bars) were 3–5%. (D) The R2/R1 ratio is plotted against
the E1-TM sequence, with the R2/R1 = 15 and R2/R1 = 20 levels marked in dotted lines.
The H1, H2 segments are designated by cylinders above the ﬁgure.
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signiﬁcant differences observed can be a reﬂection upon E1-TM struc-
ture as well as backbone motions. Based on the well-established inﬂu-
ence of rotational diffusion anisotropy upon 15N relaxation rates
[51,52], this ﬁnding could indicate that the LPPG-solubilized E1-TM as-
sembly is ellipsoidal, and that two helical domains are not co-linear. Al-
ternatively, increased internal backbonemotions on the ps-ns timescale
of H1 could also result in lower R2/R1 ratios for the former region.
To further characterize the behavior of E1-TM in its solubilizing mi-
celle, the accessibility of its amide protons to the bulk solvent wasmea-
sured. E1-TMwas dissolved in 2H2O-based buffer containing either SDS
or LPPG micelles, resulting in residue-dependent loss of tr-HSQC signal
as a function of solvent exposure. Spectra acquired for E1-TM solubi-
lized in either SDS or LPPGmicelles 30 min after exposure to deuterated
buffer displayed only cross-peaks from the H2 helix, whereas cross-
peaks from the H1 region or more ﬂexible segments were not visible
(Fig. 6). Based on theoretical calculations [53], this represents a protec-
tion factor of N104 for the H2 helix. Since the hetNOE values of both he-
lices are very similar, and considering their hydrophobic nature, it is
unlikely that the H1 is solvent exposed. We suggest that the presence
of two glycine residues in the H1 helix increases the conformational
ﬂexibility and decreases expected protection factors. In addition, resi-
dues carrying labile protons (Y361, Y362, S363) may localize the H1
helix further from themicelle core, increasing the availability of solvent
for exchange. Juxtaposed with the lower R2 values observed in H1, we
conclude that the two helices differ in the degree of internal backbone
motion they experience.
3.5. Effects of the K370A mutation
Due to its known role in heterodimerization [14], and furthermore
because of its anomalous placement as a charged residue within the li-
pophilic membrane, residue K370 presents a particularly intriguing as-
pect of LPPG-solubilized E1-TM. Having located the more ﬂexible
region of the helix in the vicinity of K370, we suspected that the charged
nature of this residuemay distort themembrane-spanning helix. To test
this hypothesis, we mutated K370 into the hydrophobic and helix-
promoting alanine residue, and re-assigned the backbone resonances
by examination of the HNCACB spectrum and comparison to the assign-
ment of wildtype E1-TM. Most signiﬁcant changes in the tr-HSQC spec-
trum were observed as expected for K370 and neighboring residues
A369 and V371, as well as non-neighboring residues G366 and V374Fig. 6. Solvent accessibility of E1-TM in SDS and LPPGmicelles. tr-1H–15N-HSQC spectra at
16.4 T and 318 K of 0.15 mM E1-TM solubilized in (A) SDS or (B) LPPG micelles 30 min
after dissolution in 2H2O-based buffer containing 20 mM NaCl and 20 mM phosphate
buffer. Only residues protected from solvent exchange are observed in such an experi-
ment. (C) E1 amide groups protected from exchange are shown for SDS (asterisks) and
LPPG (open circles).(Fig. 7A, C), presumably because these are positioned by the helical
structure in proximity to themutated residue. Smaller changeswere ex-
hibited by more distant residues, creating a distinct ‘ripple’ effect. The
emerging pattern is that residues in both H1 and H2 are affected, and
those exhibitingmore signiﬁcant effects are located on the same surface
of the helical segments. This suggests that the position of the peptide
within the stabilizingmicelle ismodiﬁed for the K370Amutant. Howev-
er, the Lys-to-Alamutation did not have a signiﬁcant effect on secondary
chemical shifts of E1-TM. Secondary chemical shifts were essentially
comparable in the wildtype and mutant peptides, and, notably, no
change was observed in the more ﬂexible region, suggesting that a sig-
niﬁcant alteration of secondary structure did not occur (Fig. 7B). We
conclude that neutralization of the K370 charge is not the dominating
cause of structural changes accompanying the E1/E2 heterodimerization
event.
4. Discussion
Heterodimerization of the E1/E2 glycoproteins has been shown to be
a mandatory step for fusion of viral and host cell membranes during in-
fection byHCV [5,12,14]. Both the extracellular domains andmembrane-
spanning helices of these glycoproteins contribute to this cellular event,
as determined by the effects of mutations located within the hydropho-
bic membrane domains, E1-TM and E2-TM, upon viral infectivity. Thus,
inhibition of the interaction between the two TM-domains is a promising
avenue for combatingHCV infection. The E1-TM/E2-TM complex forms a
bitopic membrane system, consisting of two parallel α-helical segments
with non-covalent interactions between them. Although typically these
interactions are hydrophobic in nature, E1- and E2-TM uncharacteristi-
cally have charged residues embeddedwithin themembrane, suggesting
an electrostatic interaction which increases in importance in the hydro-
phobic membrane environment.
The current lack of structural information for E1- and E2-TMwas the
primary motivation for this study. However, synthesis of membrane-
embedded peptides by chemical or recombinant methods is very chal-
lenging, since their strong aggregation tendency often frustrates such
attempts at the level of expression or puriﬁcation [54], and this hurdle
needed to be overcome as a prerequisite for any structural study of
E1/E2. We achieved this aim by fusing the E1-TM peptide via a linker
containing a proteolysis cleavage site to the MBP C-terminus. The hy-
drophobic interaction between MBP and E1-TM which precludes pep-
tide aggregation during expression persists after cleavage, as MBP and
E1-TM co-eluted under normal conditions in size-exclusion chromatog-
raphy. Separation by HPLC then yielded a pure E1-TMpeptide. A second
modiﬁcation, addition of short ﬂexible charged peptide segments at the
two E1-TM terminii, contributed aswell to the solubility of E1-TM,mak-
ing HPLC elution possible as well as future phospholipid solubilization.
Together these factors allowed a ﬁrst preparation of E1-TM samples in
membrane-mimicking environment amenable to structural study.
Both SDS- and LPPG-based micelles produced E1-TM assemblies with
stable conformations as judged by their ﬁngerprint tr-1H–15N-HSQC
spectra. Of these two surfactants, LPPG is well-known for its proven
ability to stabilize MPs for several weeks while providing a close-to-
native environment for the protein during acquisition of NMR data [22].
A combination of well-established NMR methods was employed to
characterize the assembly of E1-TM within the stabilizing micelles in
terms of micellar size and arrangement of the peptide within the mi-
celle. An analysis of secondary chemical shifts showed E1-TM to adopt
different conformations in the two micelles. In SDS micelles, E1-TM
adopted a helix–linker–helix architecture, with helical segments includ-
ing residues 354–363 and 371–379,while the intermediate segment ex-
hibited chemical shifts inconsistent with a helical conformation. In
contrast, solubilization in LPPG micelles resulted in a more helical E1-
TM, consistent with the CD results. Speciﬁcally, a helical conformation
was observed for residues 354–377, with decreased helical population
values seen for the 366–367 dyad indicating the location of a potential
Fig. 7. Effects of themembrane-embedded K370 on E1-TM structure. (A) Comparison ofﬁngerprint 15N,1H-tr-HSQC spectra for wildtype (black) and K370Amutant (red) E1-TM peptides.
Residueswith shifted resonances experience a change in chemical environment upon substitution of Ala for K370. (B) Secondary chemical shifts for 13Cα and 13Cβ nuclei ofwildtype (ﬁlled
bars) and K370A mutant (empty bars) E1-TM. (C) Chemical shifts changes induced along the E1-TM sequence by the K370A mutation, expressed as ΔHN = (ΔH2 + (ΔN/5)2)½, where ΔH
and ΔN are the individual change in 1H and 15N shifts, respectively.
Fig. 8. Summary of NMR-derived global fold and motions of LPPG-embedded E1-TM. The
E1-TM peptide (red) is schematically depicted within an LPPG micelle, with representa-
tive amino acid numbering. Helices and unstructured linkers appear in cylinders and
lines, respectively. Backbonemotions on theps-ns timescale are color coded in thepeptide
sequence, with darker shades representing more rigid regions.
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that residues 366–369 were more ﬂexible in comparison to other E1-
TM residues in the membrane-spanning domain. Occurrence of a kink
in the vicinity of residueN367 is consistentwith earlier studies identify-
ing Asn residues as a common helix-breaking residue in TM-domain, a
fact attributable to its polar sidechain which competes for hydrogen
bondingwith the backbone amides. Indeed, the kink in E1-TMwas pre-
dicted by the TMKink server [55]. The difference between SDS- and
LPPG-solubilized E1-TM appears consistent with micellar size. Thus,
the larger LPPG micelle is capable of fully accommodating a helical E1-
TM, whereas the smaller SDS micelle causes a curvature effect which
kinks the peptide at the pointmost structurally amenable to such a con-
formation.Wenote that bicelles formedby amixture of short- and long-
chain phospholipids are recognized as a more natural environment for
MPs because their shape resembles the native bilayer and they are
less prone to curvature effects [46,56]. While a study in bicelles would
be useful to verify our conclusions regarding E1-TM secondary struc-
ture, the estimated diameter of an LPPG micelle is ~40 Ǻ, which should
be sufﬁcient to avoid hydrophobic mismatch effects in a 24-residue
(354–377) canonic helix. The higher ﬂexibility of residues 366–369 ob-
served in LPPG should therefore be considered a native attribute of the
peptide.
Analysis of 15N relaxation rates along the E1-TMbackbone, in partic-
ular the elevated hetNOE values, deﬁned the micelle-embedded seg-
ment of E1-TM between residues 354–378, encompassing the GxxxG
motif and the two helical regions, with residue W353 lying at the
solvent–micelle interface, a characteristic position for Trp residues.
The global tumbling time of the E1-TM-LPPG assembly of 12 ns at
318 K is consistent with the expected size of a single peptide enclosed
within an LPPG micelle. Measured R2/R1 ratios and solvent accessibility
experiments along the membrane-spanning residues distinguished be-
tween the behavior of the H1 andH2 segments. The observed decreased
transverse relaxation rates (Fig. 5) and lower solvent exchange protec-
tion factors (Fig. 6) in H1 residues are mutually consistent and indica-
tive of increased internal motions in this region. Supporting this
conclusion are the lower secondary chemical shifts observed for this
helix (Fig. 4). It is important to note that the failure of themicelle to pro-
tect H1 amide protons from solvent exchange is not inconsistent with
its localization within the micelle hydrophobic core. It has been shown
that a glycine residuemay facilitate exchange of neighboring amide pro-
tons with solvent, and that a sequence of 5–6 consecutive hydrophobic
residues – as present in the H2 segment – is required for protection fac-
tors on the order of 103–105 [57,58]. In this context it is clear that theGxxxG motif, known for its involvement in inter-helical interactions in
MPs [59], also greatly increases backbone ﬂexibility, whichmay be nec-
essary for binding to the E2 TM helix. Structural features of LPPG-
embedded E1-TM as established in this study are summarized in Fig. 8.
Sidechains of basic amino acids located within membrane-spanning
domains are known to ‘snorkel’, i.e. adopt a conformationwhich positions
their methylene groups to contact the lipidic micelle interior while
allowing their chargedmoiety to interactwith negatively chargedmicelle
headgroups [60,61]. It has been suggested that they serve to anchor TM-
helices into a biologically-functional position within the membrane [62].
When considering the role of E1 residue K370 in glycoprotein
heterodimerization, the presence of an oppositely charged residue
(D728) in the E2 TM-domain is suggestive of formation of a membrane-
embedded salt-bridge which would provide a strong driving force for as-
sociation of the two peptides. In neutralizing this charge by mutation to
alanine we hoped to mimic the effects of heterodimerization upon E1
conformation, and discovered that secondary structure was unchanged
in the K370A mutant, suggesting that other inter-helical interactions
791H. Zazrin et al. / Biochimica et Biophysica Acta 1838 (2014) 784–792must be involved in structural changes accompanying glycoprotein
heterodimerization. The changes observed in the ﬁngerprint HSQC spec-
trum are reminiscent of the effects observed in a recent study of the β3
integrin lysine mutant, where a ‘ripple’ effect was observed for residues
on one face of the TM helix [62]. This suggests that in the K370A mutant
the helices relocate to a less polar region of the micelle interior, affecting
the ‘outer’ side of the helix while exerting a smaller effect on its ‘inner’
side. Further studies are necessary to understanding the signiﬁcance of
this molecular event in the context of glycoprotein heterodimerization.
5. Conclusions
In conclusion, we have employed a combination of NMRmethods to
investigate the behavior of the E1 membrane-spanning domain in
membrane-mimicking LPPG micelles, deﬁning the overall size of the
mixed micelle, the region embedded in the membrane, and the seg-
ments in the solubilized peptide adopting helical conformations. Be-
sides demonstrating the power of NMR to characterize the biophysical
behavior of membrane-spanning segments in the biologically impor-
tantMPs, this study lays the foundation for future studies of E1/E2 asso-
ciation which may eventually contribute to a molecular understanding
of this critical event in the life-cycle of HCV.
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